Related Experiment Video
Updated: May 30, 2026
12:09
Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
Published on: May 2, 2011
Recombinant FIXFc: a novel therapy for the royal disease?
1Rush University Medical Center, Hemophilia and Thrombophilia Center, 1653 West Congress Parkway, Chicago, IL 60612-3833, USA. lvalentino@rush.edu
Expert Opinion on Biological Therapy
|July 26, 2011
Summary
Fc fusion technology offers a promising new treatment for hemophilia B. This innovation extends the half-life of coagulation factor IX (FIX), reducing the need for frequent infusions and improving patient outcomes.
Area of Science:
- Biotechnology
- Hematology
- Protein Engineering
Background:
- Hemophilia B is a genetic disorder characterized by deficiency or absence of coagulation factor IX (FIX).
- An estimated 80,000 people worldwide are affected by hemophilia B.
- Current prophylaxis with intravenous FIX concentrate infusions is underutilized, leading to risks of severe bleeding and arthropathy.
Purpose of the Study:
- To review recent advances in therapeutic protein fusion technology for hemophilia B treatment.
- To explore the application of Fc fusion technology in extending the half-life of FIX.
Main Methods:
- Literature search of the National Library of Medicine Medline database.
- Focus on articles related to 'Fc fusion proteins' and their application in FIX deficiency.
Main Results:
- Genetically engineered recombinant FIX fused to the Fc portion of immunoglobulin significantly extends FIX half-life.
- Extended half-life reduces the required frequency of prophylactic infusions.
Conclusions:
- Fc fusion technology offers a novel therapeutic approach for hemophilia B.
- Decreased infusion frequency may increase prophylaxis adoption and adherence.
- Improved adherence can lead to better clinical outcomes for hemophilia B patients.
Related Concept Videos
01:09Recombinant DNA
Overview
01:09Recombinant DNA
Overview
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
01:29Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...